



A child watches as a worker fumigates to prevent
dengue fever and other mosquito-borne diseases,
Old Havana, Cuba, January 2008.






























































Focus | Dengue Reborn
D
engue—a viral disease that can refer to both dengue fever and
the more severe dengue hemorrhagic fever (DHF)—swept away
records again this past spring as it raged across Brazil, infecting
more than 160,000 people and killing more than 100. The reports were similar
to those out of Southeast Asia in the summer of 2007, South America the
previous spring, and India the fall before that. Although it may not be the
most devastating of the mosquito-borne diseases—malaria strikes 10 times
more people and yellow fever kills more of its victims—dengue has become a
major public health concern for two reasons: the speed with which it is spreading
and the escalating seriousness of its complications. 
In the nineteenth century, dengue fever was a mild illness found in the tropics.
Deaths were rare, and years passed between major epidemics. But since the
mid-twentieth century, the range of the dengue virus has steadily broadened.
In the last 50 years, its worldwide incidence has increased 30-fold, and various
estimates posit that anywhere from one-third to nearly one-half of the world’s
population are now at risk of becoming infected.
Aedes aegypti, the primary vector for dengue, has become perfectly adapted
to the urban environment. In the wake of discontinued eradication efforts,
Ae. aegypti has reinfested nearly every region from which it was eliminated.Moreover, today’s dengue infection is not
what it once was. DHF, a complication of
dengue infection that was not recognized
until the 1950s (although cases probably
occurred as early as 1870 in India), now
appears in many dengue epidemics. In addi-
tion to the fever, rash, headache, and muscle
and joint pain of classic dengue fever (which
earned dengue its nickname of “breakbone
fever”), DHF sometimes causes hemorrhag-
ing that can lead to shock and even death.
Epidemic DHF is now a leading cause of
hospitalization and death among children in
several Southeast Asian countries. World-
wide, of the 50 million dengue infections
estimated by the World Health Organ-
ization (WHO) each year, there are 500,000
cases of DHF and 22,000 deaths, mainly
among children.
Once considered mainly an Asian dis-
ease, dengue fever and DHF now also
permeate the tropical Americas. Between
1995 and 2001, the number of dengue cases
in the Americas doubled, according to the
WHO. By 2007, the annual incidence there
reached nearly 900,000 cases, with more
than 25,000 people suffering DHF. 
The dengue virus comes in four dis-
tinct serotypes. Individuals who become
infected with one serotype obtain lifelong
immunity against that serotype but not
against the other three—and there is good
evidence that a previous dengue infection
increases the odds of developing DHF
upon infection with a different serotype.
“Somehow, having that prior infection
enhances invasion of target cells by new
dengue [serotypes],” explains Laura
Harrington, a medical entomologist at
Cornell University. 
Dengue experts agree on many of the
causes of the disease’s spread, including
demographic changes and interruptions in
vector control efforts. But some controversy
has surfaced over whether climate change—
often cited as a factor in broadening disease
vector habitats—has had or will have any-
thing to do with the virus’s expansion. “It’s
too early to predict what effects global warm-
ing will have, if any,” says David Morens,
senior scientific advisor at the National
Institute of Allergy and Infectious Diseases
(NIAID) in Bethesda, Maryland. “But it’s
certainly something to be concerned about.”
Re-emergence of a Disease
Several factors have assisted in the spread of
dengue around the world. Aedes aegypti, the
mosquito that is the chief carrier of the
dengue virus, originated in Africa but
migrated to other continents via the slave
trade in the 1500s and 1600s, says Duane
Gubler, director of the Asia-Pacific Institute
of Tropical Medicine and Infectious
Diseases at the University of Hawaii at
Manoa in Honolulu. “As urban port cities
developed, [the Ae. aegypti] mosquito
became established and became highly
adapted to humans,” he says. Accord-
ingly, as the tropical developing world
has become increasingly urbanized
over the past few decades, Ae. aegypti
have proliferated.
Whereas Ae. aegypti  originally
bred in small natural water bodies
such as tree holes or rock pools, it now
breeds successfully in water that accu-
mulates in discarded trash such as bot-
tles, plastic and cellophane packaging,
and tires, as well as in domestic water
storage containers that are common in
places where people do not have easy
access to a regular supply of clean
water. Ae. aegypti also prefers to live
inside buildings rather than outside.
Finally, this mosquito prefers to feed
on humans, meaning viral transmis-
sion is not diluted by the mosquito
feeding on other animals as well. Ae.
aegypti therefore is “perfectly adapted
to the urban environment,” says
Gubler.
During World War II, Japanese
and Allied military movements spread
viruses throughout Southeast Asia. In
the aftermath of the war, “for the first
time, several serotypes were coming
together,” Harrington says, as people
began to travel across the world more
frequently. Subsequent economic
boom and rapid urbanization in
Southeast Asia led to conditions ideal
for epidemics—cramped living
quarters, low-quality housing, and poor
management of water, sewage, and waste
systems. Dengue’s progression from tropical
nuisance to life-threatening epidemic
reached a tipping point in the 1950s, when
DHF was first reported in the Philippines
and Thailand. 
Meanwhile, on the other side of the
globe, dengue had been largely eliminated in
the Americas, mainly thanks to attempts to
control urban yellow fever in the 1950s and
1960s. The Pan American Health Organi-
zation (PAHO), an international public
health agency, initiated a campaign to rid
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In the wake of rapid urbanization and heightened global travel since World War II, the number
of both dengue cases and countries reporting infection has climbed precipitously. 
Source: WHO; http://www.who.int/csr/disease/dengue/impact/en/index.html
Dengue since 1955: more cases, more placesCentral and South American, Caribbean,
and southern U.S. regions of Ae. aegypti,
which also transmits yellow fever virus. By
going after Ae. aegypti aggressively with the
insecticide DDT and systematically elimi-
nating its breeding areas, the campaign
largely eradicated the vector from Central
and South America, although not the
Caribbean and southern United States, says
Gubler. In the course of eradicating yellow
fever, the efforts also squashed dengue trans-
mission in the region.
DDT was banned in the United States in
1972. Coincidentally, says Gubler, Ae. aegypti
eradication efforts were deemed successful
and therefore largely abandoned, with
resources redirected to other
pressing issues of the day such
as President Richard Nixon’s
“War on Cancer.” Since then,
Ae. aegypti has returned to
nearly every region from
which it was eliminated. “We
have allowed Aedes aegypti to
reinfest most if not all of the
urban areas of tropical
America,” says Gubler.
In 1981 a serotype of
dengue imported from south-
east Asia caused an outbreak of
DHF in Cuba—the first DHF
epidemic in the Americas.
Since then, all four serotypes
have spread throughout the
Americas, causing DHF out-
breaks and becoming endemic
in many countries. 
Increased global move-
ment of people and cargo via
air travel have undoubtedly
assisted dengue’s growth, says
Harrington. It is this move-
ment that now allows mul-
tiple serotypes of dengue to
encounter each other frequently, leading to
the complications of DHF. And in the
Americas, the reinvasion of Ae. aegypti after
the lapse of eradication campaigns also con-
tributed to dengue’s resurgence, Harrington
says. “For those of us who work in dengue
research, I think there’s a fairly strong con-
sensus about what the major factors are [in
dengue’s spread],” she says.
The Climate Change Question
One factor, however, remains debatable:
the effect of climate change on the dissemi-
nation of dengue. Like many vector-borne
diseases, dengue fever shows a clear weather-
related pattern: rainfall and temperatures
affect both the spread of mosquito vectors
and the likelihood that they will transmit
virus from one human to another. In a cool
climate, the virus takes so long to replicate
inside the mosquito that most likely the
mosquito would die before it actually has a
chance to transmit the virus to another per-
son, says senior research fellow Simon Hales
of the University of Otago, New Zealand.
“There’s a consensus that climate is one of
the necessary factors that has to be right for
dengue to be able to be transmitted,” Hales
says. “Whether or not climate change will
affect the spread of dengue is probably
more contentious.”
Several studies have predicted that global
climate change could increase the likelihood
of dengue epidemics. In the 14 September
2002 issue of The Lancet, Hales and his
colleagues published an empirical model of
worldwide dengue distribution in which
they reported that annual average vapor
pressure (a measure of humidity) was the
single climate factor that best predicted
dengue fever distribution. They also used
their model to predict likely effects of
humidity on dengue distribution. If humidity
were to remain at 1990 levels into the next
century, a projected 3.5 billion people would
be at risk of dengue infection in 2085, but
assuming humidity increases as projected by
the Intergovernmental Panel on Climate
Change, the authors estimate that in fact
5.2 billion could be at risk.
Other work has reported correlations
between dengue and climate variables such
as El Niño, temperature, rainfall, and cloud
cover. In March 2008, the United Nations
Intergovernmental Panel on Climate
Change released its Fourth Assessment Report
on Climate Change Impacts: Impacts,
Adaptation and Vulnerability, concluding
that climate change could increase the num-
ber of people at risk of dengue infection. 
But some dengue researchers feel that a
case for a connection between dengue inci-
dence and climate change has yet to be
made. Global warming might influence
dengue transmission “to the extent that it
influences how water is managed and han-
dled,” says Harrington, but temperature
increases are probably not important for the
virus’s expansion. “If you really sit down and
look at the science, . . . there are no real hard
data to show that [climate change is] having
an effect,” she says. 
There’s no argument that global warm-
ing is occurring, says Gubler, but as for the
suggestion that it has played any role in the
expansion of dengue, “It’s all hype. A lot of
public health officials and a lot of policy
makers use global warming as a cop-out, an
excuse for not controlling a disease that is
very preventable.” 
In a plenary session at the May 2008
annual meeting of the American Institute of
Biological Sciences, Gubler urged that policy
makers not focus on climate change but
resume addressing the chief known drivers of
dengue’s spread—namely, population
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A systematic eradication program largely eliminated Ae. aegypti in the Americas by the 1970s. But once
the program was discontinued, the vector came back stronger than ever.
Source: Arias JR. 2002. Dengue: how are we doing? Washington, DC: Pan American Health Organization.
Ae. aegypti infestation before, during, and after 
concerted eradication efforts in the Americas
1930s 1970 2002growth, urbanization, and modern trans-
portation. Importantly, he said, “we need
political will. With political will, we may get
the economic support that we need to do the
research to develop effective prevention and
control strategies.”
But even as there is no documentation
that climate change is influencing the spread
of dengue, Hales counters there also is no
proof regarding many other factors claimed
responsible for increased dengue—such as
urbanization, population increase, and
heightened travel—and that no published
studies have attempted to assess the relative
importance of these factors in comparison to
temperature trends. It is not controversial,
he adds, that dengue is highly temperature-
sensitive, citing work published by Douglas
M. Watts and colleagues in the January
1987 issue of The American Journal of
Tropical Medicine and Hygiene showing that
temperature-induced variations in how effi-
ciently Ae. aegypti transmits the dengue virus
may be “a significant determinant” in the
annual cyclic pattern of DHF epidemics in
Bangkok.
As for whether dengue is very pre-
ventable, Hales points to the example of
Singapore, where dengue persists despite
the best efforts of this wealthy country with
its well-developed public health infrastruc-
ture and vector control. Hales concedes that
it’s too soon to say for sure whether climate
change is promoting the spread of dengue,
but that “other things being equal, we
would expect [the disease] to spread with
projected climate change.” If Earth warms
as expected, “then a larger area of the planet’s
surface will be climatically suitable for
dengue,” he says.
Global transport has
helped another dengue vec-
tor spread to new territory.
An article in the September
1987 issue of the Journal of
the American Mosquito
Control Association noted
that the Asian tiger mos-
quito, Aedes albopictus,
spread worldwide through
the international trade in
used tires. Over the past 25
years, the relatively cold-
hardy Ae. albopictus has
invaded many U.S. states,
and rising average tempera-
tures raise the possibility
that the vector could move
even further north. 
Ae. albopictus is occa-
sionally an important
dengue vector in rural and
suburban areas in Southeast
Asia, says Philip McCall, a
medical entomologist at
the Liverpool School of
Tropical Medicine, United
Kingdom, and it was also
behind Hawaii’s 2001 out-
break of 122 cases on the
island of Maui. But Gubler
says it is a mistake to
assume that dengue epi-
demics will necessarily
result from the spread of
Ae. albopictus. Although
this mosquito has been
shown to be a highly effi-
cient carrier in controlled
experiments, it is far less so
in real-world situations, he
explains, mainly because it
feeds on both humans and
nonhuman animals, and it
prefers rural environments
to urban settings. If Ae.
albopictus populations were
to displace Ae. aegypti, then
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A
B
Scientists recently modeled the estimated baseline population at risk for dengue infection in 1990 (A) and
in 2085 (B) using climate data for 1961–1990 and projections for humidity change—a function of climate
change—for 2080–2100. Ranges above indicate percentage of the population at risk: 0–10%, 10–20%, etc.
However, many scientists do not agree that climate change will appreciably alter the risk of dengue. 
Source: Hales S, et al. 2002. Potential effect of population and climate changes on global distribution of
dengue fever: an empirical model. Lancet 360:830–834.
Will climate change affect the spread of dengue in coming years?that could actually lead to reduced risk of
dengue transmission, Gubler says. 
A Disease of Poverty
Dengue is a disease of poverty, Hales says.
“In the places where it’s really rife, typically
urban shantytowns, people have got very
poor services,” he explains. “Waste is piling
up in the street. There’s no running water,
so people have to collect water in vessels,
which then breed mosquitoes. The people
have got terrible housing, so they’re not able
to protect themselves from getting bitten.
And they’re living in very close proximity.
It’s the perfect recipe for a huge epidemic.”
Even if today’s temperate latitudes did
become more suitable for dengue transmis-
sion, Gubler says, most of those regions are
more developed and have good enough
housing and water supply that dengue epi-
demics would remain unlikely. The standard
of living in the United States will likely pre-
vent any major dengue epidemics. “The
United States is not going to have major epi-
demics of vector-borne diseases unless we
allow our public health system to deteriorate
completely,” Gubler says. 
But professor Peter Hotez of The Sabin
Vaccine Institute and George Washington
University worries about the effect of dengue
and other diseases he calls “neglected infec-
tions of poverty” on the poorest people in
the United States. “There’s always been this
reservoir of people at risk, and my concern is
that, because they’re poor and voiceless, we
ignore them,” he says.  
Although dengue is endemic in Puerto
Rico (where it has caused epidemics since
the 1960s), it is absent from most of the
continental United States, except in travelers
returning from tropical locales. However,
the disease appears occasionally along the
U.S.–Mexico border, Hotez says. Along the
border, reported incidence is much higher in
the Mexican states than the U.S. ones, prob-
ably because of different living standards—
window screens, air conditioning, and effec-
tive sanitation may help keep dengue at bay
on the U.S. side, Hotez says.
However, a study published in the
October 2007 issue of Emerging Infectious
Diseases found that dengue incidence was
surprisingly high in the border town of
Brownsville, Texas. The researchers found
evidence of past dengue infection in 40% of
Brownsville residents. People with low
income, no air conditioning, and poor street
drainage were most likely to have suffered
infection. 
In a review published 25 June 2008 in
PLoS Neglected Tropical Diseases, Hotez esti-
mated as many as 200,000 U.S. cases of
dengue fever occur each year, “but the esti-
mates are pretty wide-ranging,” he says.
There have so far been few reports of DHF
in the United States. However, Hotez points
out that DHF outbreaks have happened as
close as Cuba; therefore, he says, “so there’s
every reason to believe that it could happen
in the United States.”
Many of the people at risk of dengue
infection in the United States are members
of minority groups, Hotez says—something
that also applies to other infections that
many people think of as “tropical” disease.
Besides dengue, low-income Hispanic
communities near the Mexican border are
also at risk of Chagas disease, cutaneous
leishmaniasis, and cysticercosis, an infection
caused by ingesting tapeworm eggs, which is
now a leading cause of epilepsy and seizures
in areas around the U.S.–Mexico border.
Many of these infections have been around
for a while, Hotez says; however, “We’ve just
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Dengue is transmitted by mosquitoes that have become perfectly adapted to the urban
environment. Areas where there is poor sanitation and overcrowding (such as Rio de
Janeiro, Brazil, above and below) are ripe for epidemics. According to the Brazilian
Ministry of Health, Rio was the site of about half the dengue cases in an epidemic that
swept this country in spring 2008.ignored and neglected them because we tend
not to pay attention to the plight of the poor
and underrepresented minorities.”
Hotez suspects that people living in
other areas prone to neglected infections—
especially the post-Katrina Gulf Coast and
elsewhere in the Mississippi River delta—are
at some risk of dengue, but few data have
been collected. “It’s not clear how many
cases of dengue infection there are each year
in the United States,” he says. “We’re not
doing aggressive surveillance.” 
Curbing Dengue’s
Expansion 
Researchers are coming at
dengue from a variety of
angles to try to curb the
virus’s spread. There are
no available vaccines or
antivirals for dengue
infection, leaving mos-
quito control as the only
current method for pre-
vention and control. 
“Ultimately, we need
a vaccine for dengue,”
says Harrington. “That’s
probably the only way
that we’re going to be able




of the four different virus
serotypes in circulation.
Because DHF usually
occurs when an individual
already has immunity against one dengue
serotype, researchers fear that vaccines that
fail to provide equal immunity against all
four serotypes may actually predispose
people to hemorrhagic complications if they
encounter a novel serotype after being vacci-
nated. “That has really slowed the develop-
ment of the dengue vaccine,” Hotez says. 
Currently, researchers at the Korea-based
Pediatric Dengue Vaccine Initiative, chaired
by Gubler and funded by the Bill &
Melinda Gates Foundation, are facilitating
the development of several different tech-
nologies to overcome those obstacles, for
example, by helping some companies with
clinical trials, establishing field sites, and
working with developing countries to create
the infrastructure to manage eventual vac-
cine distribution.
As part of the Grand Challenges in
Global Health program, also funded in part
by the Gates Foundation, researchers are
creating mosquitoes that are genetically
incapable of transmitting the dengue virus.
About a dozen scientists worldwide are
tackling different facets of the project, says
Harrington, whose laboratory is assessing
whether the transgenic strains are likely to
outcompete Ae. aegypti for resources and
mates in the wild. “If you could dream
about something that could really make an
impact, this would be it,” she says. 
For now, dengue control still relies heav-
ily on controlling the mosquito that trans-
mits it. McCall and his colleagues have been
running studies in Latin America and
Southeast Asia to judge the effectiveness of
household-based insecticide-treated materials
(such as window curtains) and domestic
water container covers as foils to the mos-
quito carriers and dengue transmission.
Also, scientists from Vietnam and Australia
reported in the January 2005 issue of The
American Journal of Tropical Medicine and
Hygiene that cultivating a natural predator
of Aedes mosquitoes, the tiny crustacean
Mesocyclops, in water storage containers vir-
tually eliminated Ae. aegypti populations. “I
was amazed,” McCall says. “I’m often skep-
tical about biological control, but in
Vietnam, when used in combination with
clean-up and education campaigns, this
seems to have been spectacularly successful.”
Research continues on all fronts, adding
to the collective knowledge about dengue
transmission and, in some cases, challeng-
ing long-held assumptions. A mathematical
model published by Suwich Thammapalo
and colleagues in the 12 February 2008
issue of Proceedings of the National
Academy of Sciences showed that decreasing
dengue transmission may sometimes cause
an increase in cases of DHF. The model’s
predictions were boosted by epidemiologic
data from Thailand that were later pub-
lished 16 July 2008 in PLoS Neglected
Tropical Diseases. The authors of both
papers speculate that the effect may arise
from a brief, transient cross-protection that
people experience when infected with one
serotype of dengue. At very high levels of
dengue transmission, people could then
have immunity to all four serotypes of the
virus. If transmission is reduced moderately,
this cross-immunity
would also be reduced.
The results are contro-
versial, McCall says, “but
many in the field believe
it to be the case.”
Not everyone agrees,
however, and Harring-
ton summarizes some of





tion and transmission as
a function of mosquito
abundance as measured
using the Breteau index,
which reflects the num-
ber of water containers
with mosquito larvae in
100 randomly selected
houses in a community.
But the Breteau index is
a poor estimate of mos-
quito abundance, she says, and it rarely
indicates what species is abundant.
Moreover, it does not provide a large
enough sample size to be powerful and
meaningful.
“This type of work is a prime example of
scientists working in isolation,” she says. “It
highlights the need for cross-collaborative
work on models for dengue ecology and epi-
demiology where biologically meaningful
models can be developed.”
According to Hales, some of the most
promising solutions may not directly
involve mosquito eradication and may have
little to do with technology. “What people
[at risk] need is a decent environment in
which to live,” he says. “If we had a dengue
vaccine, most likely those people wouldn’t
be able to afford it anyway. I’m not saying
don’t look for a vaccine, but that’s probably
not a short-term answer for the problem
for these people.”
Melissa Lee Phillips
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A worker fumigates a house in Old Havana, Cuba, January 2008. Control of mos-
quitoes with pesticides is one of the few methods currently available to rein in
dengue. Systematic habitat destruction also has proved effective in the past.